can glp 1 cause liver damage Effects of GLP-1 receptor agonists on the degree of fibrosis and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis MASLD (Nonalcoholic Fatty Liver Disease)

I am especially honored to receive the 2026 Kimberly Prize for my work on the biochemistry and physiology of GLP-1, Mojsov said

Summary Keywords drug-repositioning, thyroid-cancer, anti-diabetic, metformin, diabetes Citation Greco A, Coperchini F, Croce L, Magri F, Teliti M and Rotondi M (2023) Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs

GLP-1 agonists are not a replacement for antihypertensive therapy but may complement it

These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1

Reach out today to connect with a registered dietitian who can support your success on GLP-1 therapy and beyond